Trial reportBMC oral health2025
24-month randomized controlled clinical trial assessment of surface texture, color stability, and marginal discoloration of sonic activated bulk-fill resin composite according to USPHS and FDI criteria.
Trial report in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Performance of Sonic-Activated High Viscosity Bulk-Fill Resin Composite in Comparison to Conventional Bulk-Fill Resin Composite Restorations in Posterior Teeth: A Randomized Controlled Clinical Study.
Clinical Assessment of Viscosity-Modified Composite Resins: Preheated, Sonic Activated, and Flowable Resins in Class V Restorations
Assessment of Clinical, Radiographic, and Oral Health-Related Quality of Life Following Restoration of First Permanent Molars With Cention-N: A 12-Month Split-Mouth Randomized Controlled Trial
Who cites it
2 citing papers in PubMed.
- Clinical performance of an innovative self-cure bulk-fill composite compared to dual-cure and light-cure bulk-fill composite in posterior restorations: a 1-year randomized controlled clinical trial.Clinical oral investigations · 2026Trial
- Clinical evaluation of different bi-layer biomimetic strategies of composite resin in large class I cavities: an 18-month randomized clinical trial.BMC oral health · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess the surface texture, color stability, and marginal discoloration of sonic-activated bulk-fill resin composite (BFRC) in comparison to non-sonic-activated BFRC, over 24 months, by two different evaluation criteria.
methods30 adult patients, each presented with at least two carious lesions, either Class I or Class II cavities in their posterior teeth, were selected and subdivided randomly into two identical groups: one group restored with Sonicfill 3 and the other group restored with the X-tra fill, with total of 60 restorations for both groups. Surface texture, color stability, and marginal discoloration were assessed at baseline (1 week), then at 3, 6, 12, and 24-month periods, applying the modified United States Public Health Services (USPHS) criteria and World Dental Federation (FDI) criteria.
resultsAfter the 24-month follow-up evaluation period, there was a non-significant difference in the clinical outcomes between both tested groups, with a non-statistical difference between the results' outcomes evaluated by USPHS or FDI criteria, where all restorations were considered clinically successful by both criteria.
conclusionsThe surface texture, color stability, and marginal discoloration of both tested BFRCs over 24 months were considered clinically successful, either with or without the use of sonic energy. Regarding both criteria, they were reliable, comparable, and suitable for evaluating the clinical performance of RC restorations.
trial registrationThe current study underwent registration at www. CLINICALTRIALS: gov and obtained the unique identification number NCT04926883 for its protocol on 03/06/2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.